Dafna-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
83
Total Value
352661806
Accession Number
0001389933-25-000002
Form Type
13F-HR
Manager Name
Dafna-Capital-Management
Data Enrichment
94% identified
78 identified5 unidentified

Holdings

83 positions
Manager:
Search and click to pin securities to the top
Page 5 of 5
Black Diamond Therapeutics, Inc.
Shares:140.0K
Value:$217.0K
Spero Therapeutics, Inc.
Shares:125.0K
Value:$90.0K
Tenaya Therapeutics, Inc.
Shares:47.3K
Value:$27.0K